GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures


   TAGS:     Parkinson

Study Description: Researchers think that inflammation is thought to either trigger Parkinson's disease (PD), make the symptoms worse or contribute to the progression of the disease. Although inflammation may at first be beneficial because it is the body's natural response to combat infection, prolonged and uncontrolled inflammation causes brain damage. The purposes of this study are to (1) examine the blood, urine and spinal fluid of persons with PD to look for evidence of inflammation and its association with the level of inflammation; (2) whether vitamin B3 supplements may reduce the inflammation and/or improve symptoms.

Contact for Enrollment

    
     (706) 721-1106
    cwakade@gru.edu

    Submit Information Online

Principal Investigator: Chandramohan Wakade

Eligibility Criteria: Men and women subjects diagnosed with Parkinson's disease (PD). Subjects who do not have PD (i.e., healthy or have other medical conditions) will serve as control subjects.

Compensation: Yes, subjects will be compensated.

Compensation Explanation: Subjects who complete the 6-month study will be given a $50 gift card. They will receive an additional $100 if they participate in the spinal draw.

 

Didn't find a study to participate in?

If you don't see specific studies that interest you, please submit your contact information for future studies.